| Literature DB >> 24283505 |
Amelia Draper1, Lucinda Jude, Georgina M Jackson, Stephen R Jackson.
Abstract
Tourette syndrome (TS) is a neurodevelopmental disorder characterized by the occurrence of motor and vocal tics. TS has been linked to the impaired operation of cortical-striatal-thalamic-cortical circuits that give rise to hyper-excitability of cortical motor areas, which may be exacerbated by dysfunctional intra-cortical inhibitory mechanisms. That said, many individuals gain control over their tics during adolescence and it has been suggested that this increased control arises as a result of the development of mechanisms that operate to suppress corticospinal excitability (CSE) ahead of volitional movements. Here we used single-pulse transcranial magnetic stimulation (TMS) in conjunction with a manual Go/NoGo task to investigate alterations in CSE ahead of volitional movements in a group of adolescents with TS (N = 10). Our study demonstrated that CSE, as measured by TMS-induced motor-evoked potentials (MEPs), was significantly reduced in the TS group in the period immediately preceding a finger movement. More specifically, we show that individuals with TS, unlike their age-matched controls, do not exhibit the predicted increase in mean MEP amplitude and decrease in MEP variability that immediately precede the execution of volitional movements in typically developing young adults. Finally, we report that the magnitude of the rise in MEP amplitude across the movement preparation period in TS is significantly negatively correlated with clinical measures of motor tic severity, suggesting that individuals with severe motor tics are least able to modulate motor cortical excitability.Entities:
Keywords: Go/NoGo task; Tourette syndrome; inhibition; motor excitability; transcranial magnetic stimulation (TMS); volitional movements
Mesh:
Year: 2013 PMID: 24283505 PMCID: PMC4374703 DOI: 10.1111/jnp.12033
Source DB: PubMed Journal: J Neuropsychol ISSN: 1748-6645 Impact factor: 2.864
Clinical characteristics of Tourette syndrome participants
| ID | Age | Gender | YGTSS | Motor tic scores | Phonic tic scores | Co-morbidity | Medication |
|---|---|---|---|---|---|---|---|
| TS006 | 20 | M | 40 | 14 | 16 | None | Clonidine |
| TS018 | 17 | M | 22 | 12 | 0 | ADHD | Clonidine |
| TS028 | 17 | F | 41 | 10 | 11 | OCD | None |
| TS071 | 12 | M | 33 | 15 | 13 | OCD | None |
| TS013 | 17 | M | 47 | 11 | 6 | OCD | None |
| TS067 | 17 | M | 29 | 14 | 0 | None | Clonidine |
| TS069 | 11 | M | 24 | 14 | 5 | None | None |
| TS074 | 12 | M | 33 | 14 | 9 | None | None |
| TS034 | 14 | M | 25 | 7 | 8 | None | None |
| TS062 | 16 | M | 65 | 24 | 21 | None | Citalopram |
Note.
YGTSS = Yale Global Tic Severity Scale; ADHD = attention deficit hyperactivity disorder; OCD = obsessive–compulsive disorder.
Figure 1Mean motor-evoked potential (MEP) amplitudes for each group and each condition/period (i.e., NoGo trials, Go trials 0–60%, 61–80%, 81–100% of the movement preparation period). Error bars are SEM.
Figure 2Mean motor-evoked potential (MEP) amplitudes for each group for period of movement preparation time (i.e., 0–60%, 61–80%, and 81–100%) expressed as a ratio of mean MEP amplitude on no movement (i.e., correct NoGo) trials. Note the broken horizontal line indicates a ratio of 1.
Mean and SD for coefficients of variation for each group
| Period | CS group: coefficient of variation | TS group: coefficient of variation | ||
|---|---|---|---|---|
| Mean | Mean | |||
| 0–60% | 0.47 | 0.17 | 0.40 | 0.17 |
| 61–80% | 0.35 | 0.18 | 0.40 | 0.23 |
| 80–100% | 0.24 | 0.14 | 0.36 | 0.34 |
SD = standard deviation; CS = control subjects; TS = Tourette syndrome.
Figure 3Relationship between motor tic severity, as assessed by the Yale Global Tic Severity Scale (YGTSS) motor tic sub-scale, and linear slope function calculated for each Tourette syndrome (TS) participant separately that describes the rise in motor-evoked potential (MEP) amplitude as a function of time through the movement preparation period.